Northern Trust Corp Harrow Health, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Harrow Health, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 296,818 shares of HROW stock, worth $10.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

296,818

Previous 290,036 2.34%

Holding current value

$10.9 Million

Previous $6.06 Million 120.27%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$20.85 - $46.47 $141,404 - $315,159	6,782 Added 2.34%	296,818 $13.3 Million
Q2 2024 Aug 14, 2024	SELL	$10.0 - $21.64 $270,450 - $585,253	-27,045 Reduced 8.53%	290,036 $6.06 Million
Q1 2024 May 14, 2024	BUY	$9.3 - $13.23 $2,362 - $3,360	254 Added 0.08%	317,081 $4.19 Million
Q4 2023 Feb 13, 2024	BUY	$8.1 - $16.36 $90,096 - $181,972	11,123 Added 3.64%	316,827 $3.55 Million
Q3 2023 Nov 13, 2023	BUY	$14.03 - $22.08 $367,628 - $578,562	26,203 Added 9.37%	305,704 $4.39 Million
Q2 2023 Aug 11, 2023	BUY	$17.37 - $28.08 $3.23 Million - $5.22 Million	186,033 Added 199.03%	279,501 $5.32 Million
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $65,615 - $101,741	4,741 Added 5.34%	93,468 $1.98 Million
Q4 2022 Feb 13, 2023	BUY	$10.28 - $14.78 $1,665 - $2,394	162 Added 0.18%	88,727 $1.31 Million
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $13,277 - $50,282	2,021 Added 2.34%	88,565 $1.07 Million
Q2 2022 Aug 12, 2022	SELL	$5.75 - $7.74 $557 - $750	-97 Reduced 0.11%	86,544 $630,000
Q1 2022 May 13, 2022	SELL	$6.77 - $8.66 $16,518 - $21,130	-2,440 Reduced 2.74%	86,641 $591,000
Q4 2021 Feb 08, 2022	SELL	$8.5 - $12.0 $4,564 - $6,444	-537 Reduced 0.6%	89,081 $770,000
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $11,135 - $16,885	-1,593 Reduced 1.75%	89,618 $815,000
Q2 2021 Aug 13, 2021	SELL	$6.68 - $11.07 $1.22 Million - $2.02 Million	-182,726 Reduced 66.7%	91,211 $847,000
Q1 2021 May 12, 2021	SELL	$6.26 - $11.03 $317,619 - $559,640	-50,738 Reduced 15.63%	273,937 $1.85 Million
Q4 2020 Feb 11, 2021	SELL	$4.76 - $6.93 $84,261 - $122,674	-17,702 Reduced 5.17%	324,675 $2.23 Million
Q3 2020 Nov 16, 2020	BUY	$4.71 - $7.36 $804,336 - $1.26 Million	170,772 Added 99.51%	342,377 $1.91 Million
Q2 2020 Aug 14, 2020	BUY	$3.61 - $6.47 $430,763 - $772,032	119,325 Added 228.24%	171,605 $894,000
Q1 2020 May 14, 2020	BUY	$3.5 - $7.31 $4,259 - $8,896	1,217 Added 2.38%	52,280 $200,000
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $7,189 - $12,316	1,563 Added 3.16%	51,063 $397,000
Q3 2019 Nov 13, 2019	BUY	$4.89 - $8.0 $1,007 - $1,648	206 Added 0.42%	49,500 $278,000
Q1 2019 May 13, 2019	BUY	$4.75 - $7.1 $234,146 - $349,987	49,294 New	49,294 $245,000

Others Institutions Holding HROW

# of Institutions

177

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Harrow Health, Inc. Transaction History